SlideShare a Scribd company logo
1 of 13
COVID 19: RESPIRATORY CONDITIONS
www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér
Asthma
• Asthmatics with mild–moderate disease usually have normal lungs when well controlled.
• Maintenance therapy will not require changing when they are well as as inhaled
corticosteroids from used in asthma therapy have not been shown to be
immunosuppressant and should be continued.
• BTS guidelines on provision of a rescue pack for patients with a good understanding of
their personalised asthma action plan may be sensible in the current health climate.
Issue a peak flow meter so they can monitor at home. Rescue packs should be issued as
acute and SHOULD NOT be on repeat as each exacerbation requires a review.
• Acute exacerbations of asthma should be treated in the normal way, including oral
steroids.
www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér
Acute asthma vs. COVID-19
• Differentiating an acute exacerbation of asthma from COVID-19 may be difficult.
Pragmatically, fever and change of taste/smell are unusual in asthma. Decide (as
best you can) which is more likely. If COVID-19 suspected, remember:
• Oral steroids are NOT a treatment for COVID-19. In practice, this means that if an
asthmatic has mild COVID symptoms but with no significant asthma symptoms,
we should not give prophylactic oral steroids.
• However, if typical asthma exacerbation features are dominant
(wheeze/bronchospasm), oral steroids should be used as per asthma guidelines.
Use shortest duration.
• Twice as much steroids when ill under the guidance of medical practitioner.
www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér
ASTHMA
www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér
Concern Management
Wheeze/Bronchospasm
But
NO fever
Treat as an exacerbation.
Possible COVID-19 ie
SOB/Cough/fever
 Fever: Paracetamol & oral fluids
 Possible Secondary Bacterial Pneumonia:
As per severity of symptoms choose:
Moderate: Amoxicillin 500mg TDS+ Clarithromycin
500mg BD for 7 days
OR
Doxycycline 200mg stat and then 100mg OD for 6
days
Moderately severe: Co-Amoxiclav 625mg TDS +
Clarithromycin 500mg BD for 7 days
OR
Azithromycin 500mg OD for 5/7 Days (If no other
option).
 Wheezing/SOB: High dose of SABA (4-8 puffs
via large volume spacer). Do not introduce
nebules, only to be used if patient previously
using nebules.
COPD
• There is NO evidence for ‘just in case antibiotics’ OR using
prophylactic antibiotics.
• Treat apparent exacerbations as you normally would,
irrespective of possible organism, which means:
• Use antibiotics if suspected bacterial infective exacerbations
(more sputum/change in sputum colour).
• Consider oral steroids for increased breathlessness: but first
check that symptoms can’t be managed with increasing
bronchodilators, breathing exercises, pacing. Have a lower
threshold to use steroids in those with asthma–COPD
overlap or previous raised eosinophils as they are likely to
get greater benefits. Do not use if patient has a fever. If
using, offer 30mg prednisolone for 5 days.
• Remember, anxiety can also drive
breathlessness/tachycardia: a phone/video consultation can
help reassure people.
www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér
If oxygen sats are available, a significant change from
baseline is:
www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér
Mild: <2%
below
baseline
Moderate: 3–
4% below
baseline sats
Severe: ≥5%
below
baseline sats
www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér
COPD Worsening SOB
But
No Fever
 Use high dose SABA (4-8 puffs via large volume spacer). Do
not introduce nebules, however, if patient has already got
nebules may step up the dose.
 Oral steroids only to be considered if
1. Mixed COPD+ Asthma
2. COPD with h/o high Eosinophil ≥0.3
COPD Increase sputum amount/
Sputum discolouration
BUT
No chest pain
No fever
No loss of Activity of Daily
Living (ADL)
Treat as infective COPD Exacerbation
Reminder (No oral steroids to be used)
COPD : POSSIBLE COVID 19
Possible COVID-19 with
SOB/New continuous cough/ fever/ Chest tightness or pain/ Decline in ADL/Lethargy
www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér
 Fever: Paracetamol and oral fluids.
 Secondary bacterial Pneumonia
As per severity of symptoms choose:
Moderate: Amoxicillin 500mg TDS+ Clarithromycin 500mg BD for 7 days
OR
Doxycycline 200mg stat and then 100mg OD for 6 days
AND:
Treat SOB using SABA high dose via large volume spacer. Patient may use nebules if has got them at home.
Moderately severe: Co-Amoxiclav 625mg TDS + Clarithromycin 500mg BD for 7 days
OR
Azithromycin 500mg OD for 5/7 Days (If no other option). Please note this group may be appropriate for COVID-HOT
hub assessment and management
AND
 Treat SOB using SABA high dose via large volume spacer. Patient may use nebules if has got them at home.
Interstitial Lung Disease
www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér
 Currently under Shielding (12 weeks)
 Will not do well with intubation/ mechanical
ventilation
 Likely to become hypoxic very quickly
 Mostly have advanced care plan in place
If has developed symptoms of possible COVID-19 →
 Admission will be guided by deterioration of SpO2
from baseline (up to 2% decline is mild, 2-4% is
moderate and ≥5% decline from baseline is severe
deterioration)
 Consult Advanced care plan for management
decisions
 Antifibrotic Biologics can be paused for up to 8 weeks
 Do not stop Long term Oral Steroids
 DMARDs to be paused and re-initiated 2 weeks after
recovery.
 Elongate the shielding time (Beyond 12 weeks)
Obstructive Sleep Apnea
www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér
Have normal Lung function
Should they develop COVID-19 symptoms
(A new continuous cough/fever/chest
tightness/SOB/lethargy/decline in ADL)
follow the decision tree as for all
members of public
Should these patient
need hospitalisation,
advise to take CPAP
machine with them to use
at hospital
Bronchietasis
Development of
discoloured purulent
sputum
But
No chest pain
No fever
No loss of Activity of
Daily Living (ADL)
Treat as an exacerbation
with standard dose
Amoxicillin or Doxycycline
for 10-14 days
Do not collect sputum
samples
If non-respondent to the
above may consider
Ciprofloxacin but seek
specialist advice.
Bronchietasis: Possible COVID 19
www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér
Possible COVID-19 i.e.
• SOB/New continuous cough/ fever
• Chest tightness or pain
• Decline in ADL
• Lethargy With/without purulent
sputum
Fever: Paracetamol and oral fluids
+
As per severity of symptoms choose:
Moderate: Amoxicillin 500mg TDS+ Clarithromycin 500mg BD for 7 days
OR
Doxycycline 200mg stat and then 100mg OD for 6 days
AND:
Treat SOB using SABA high dose via large volume spacer. Patient may use nebules if has got them at
home.
Moderately severe: Co-Amoxiclav 625mg TDS + Clarithromycin 500mg BD for 7 days
OR
Azithromycin 500mg OD for 5/7 Days (If no other option).
Please note this group may be appropriate for COVID-HOT hub assessment and management
References
• References:
• http://primarycarepathways.co.uk/covid-19/clinical-
assessment/pathways/177-barnet-primary-care-pathway-during-covid19-
v2-0-pdf/file
• Accessed 03/04/2020
• http://primarycarepathways.co.uk/covid-19/clinical-assessment/241-
primary-care-and-community-respiratory-resource-pack-during-covid-19-
nhs-london-clinical-networks/file
• Accessed 03/04/2020
• The above guidance is correct and up to date as of 03/04/2020. It is subject
to amendment as the pandemic progresses.
www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni
Amblum-Almér

More Related Content

What's hot

Approche to acute asthma management
Approche to acute asthma managementApproche to acute asthma management
Approche to acute asthma managementANAS ALSOHLE
 
Diagnosis &amp; management of status asthmaticus
Diagnosis &amp; management of status asthmaticusDiagnosis &amp; management of status asthmaticus
Diagnosis &amp; management of status asthmaticusSheela Aglecha
 
Childhood asthma 2021
Childhood asthma 2021Childhood asthma 2021
Childhood asthma 2021Imran Iqbal
 
Childhood asthma diagnosis and management
Childhood asthma diagnosis and managementChildhood asthma diagnosis and management
Childhood asthma diagnosis and managementVirendra Hindustani
 
Childhood asthma - etiopathogenesis,clinical manifestations and evaluation
Childhood asthma - etiopathogenesis,clinical manifestations and evaluationChildhood asthma - etiopathogenesis,clinical manifestations and evaluation
Childhood asthma - etiopathogenesis,clinical manifestations and evaluationLokanath Reddy Mummadi
 
Asthma exacerbation case study in pediatrics
Asthma exacerbation case study in pediatricsAsthma exacerbation case study in pediatrics
Asthma exacerbation case study in pediatricsLyndon Woytuck
 
83608028 acute-bronchitis-case-study
83608028 acute-bronchitis-case-study83608028 acute-bronchitis-case-study
83608028 acute-bronchitis-case-studyhomeworkping3
 
Day 1 | CME- Trauma Symposium | Bronchiolitis pittenger
Day 1 | CME- Trauma Symposium | Bronchiolitis pittengerDay 1 | CME- Trauma Symposium | Bronchiolitis pittenger
Day 1 | CME- Trauma Symposium | Bronchiolitis pittengerNorton Healthcare
 
Paeds sob version 2
Paeds sob version 2Paeds sob version 2
Paeds sob version 2drianturner
 
Bronchiolitis
BronchiolitisBronchiolitis
BronchiolitisLm Huq
 
Acute severe asthma management 2020
Acute severe asthma management 2020Acute severe asthma management 2020
Acute severe asthma management 2020Mohamed Metwally
 
COPD presentation
COPD presentationCOPD presentation
COPD presentationKathy Chow
 
Bronchial asthma in pediatric age groups
Bronchial asthma in pediatric age groupsBronchial asthma in pediatric age groups
Bronchial asthma in pediatric age groupsShambhavi Sharma
 
Evidence based Management of acute severe asthma
Evidence based Management of acute severe asthmaEvidence based Management of acute severe asthma
Evidence based Management of acute severe asthmaDr Rakesh Kumar
 
Pediatric asthma diagnosis
Pediatric asthma diagnosisPediatric asthma diagnosis
Pediatric asthma diagnosishisham alrabty
 
a case presentation on Acute bronchitis
 a case presentation  on Acute bronchitis  a case presentation  on Acute bronchitis
a case presentation on Acute bronchitis Anvy Anvia
 

What's hot (20)

Approche to acute asthma management
Approche to acute asthma managementApproche to acute asthma management
Approche to acute asthma management
 
Diagnosis &amp; management of status asthmaticus
Diagnosis &amp; management of status asthmaticusDiagnosis &amp; management of status asthmaticus
Diagnosis &amp; management of status asthmaticus
 
Childhood asthma 2021
Childhood asthma 2021Childhood asthma 2021
Childhood asthma 2021
 
Childhood asthma diagnosis and management
Childhood asthma diagnosis and managementChildhood asthma diagnosis and management
Childhood asthma diagnosis and management
 
Bronchiolitis | Case Study
Bronchiolitis | Case StudyBronchiolitis | Case Study
Bronchiolitis | Case Study
 
Childhood asthma - etiopathogenesis,clinical manifestations and evaluation
Childhood asthma - etiopathogenesis,clinical manifestations and evaluationChildhood asthma - etiopathogenesis,clinical manifestations and evaluation
Childhood asthma - etiopathogenesis,clinical manifestations and evaluation
 
Asthma exacerbation case study in pediatrics
Asthma exacerbation case study in pediatricsAsthma exacerbation case study in pediatrics
Asthma exacerbation case study in pediatrics
 
83608028 acute-bronchitis-case-study
83608028 acute-bronchitis-case-study83608028 acute-bronchitis-case-study
83608028 acute-bronchitis-case-study
 
Day 1 | CME- Trauma Symposium | Bronchiolitis pittenger
Day 1 | CME- Trauma Symposium | Bronchiolitis pittengerDay 1 | CME- Trauma Symposium | Bronchiolitis pittenger
Day 1 | CME- Trauma Symposium | Bronchiolitis pittenger
 
Paeds sob version 2
Paeds sob version 2Paeds sob version 2
Paeds sob version 2
 
Bronchiolitis
BronchiolitisBronchiolitis
Bronchiolitis
 
Acute severe asthma management 2020
Acute severe asthma management 2020Acute severe asthma management 2020
Acute severe asthma management 2020
 
COPD presentation
COPD presentationCOPD presentation
COPD presentation
 
Bronchial asthma in pediatric age groups
Bronchial asthma in pediatric age groupsBronchial asthma in pediatric age groups
Bronchial asthma in pediatric age groups
 
Acute bronchiolitis ppt
Acute bronchiolitis pptAcute bronchiolitis ppt
Acute bronchiolitis ppt
 
Evidence based Management of acute severe asthma
Evidence based Management of acute severe asthmaEvidence based Management of acute severe asthma
Evidence based Management of acute severe asthma
 
Pediatric asthma diagnosis
Pediatric asthma diagnosisPediatric asthma diagnosis
Pediatric asthma diagnosis
 
Bronchiolitis
BronchiolitisBronchiolitis
Bronchiolitis
 
meningitis
meningitismeningitis
meningitis
 
a case presentation on Acute bronchitis
 a case presentation  on Acute bronchitis  a case presentation  on Acute bronchitis
a case presentation on Acute bronchitis
 

Similar to Covid 19 Respiratory

Cough, diagnosis and its treatment
Cough, diagnosis  and its treatmentCough, diagnosis  and its treatment
Cough, diagnosis and its treatmentLok Raj Bhandari
 
Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Gabriel Guevara MD
 
Paediatrics house officer guide hospital kulim
Paediatrics house officer guide hospital kulimPaediatrics house officer guide hospital kulim
Paediatrics house officer guide hospital kulimSalman Syn
 
L2 bronchial asthma
L2 bronchial asthmaL2 bronchial asthma
L2 bronchial asthmabilal natiq
 
Cold and flu, its diagnosis and treatment for Pharmacist
Cold and flu, its diagnosis and treatment for PharmacistCold and flu, its diagnosis and treatment for Pharmacist
Cold and flu, its diagnosis and treatment for PharmacistLok Raj Bhandari
 
Approach patient with cough
Approach patient with cough Approach patient with cough
Approach patient with cough SoM
 
Cough responding to symptoms lec. 2
Cough  responding to symptoms lec. 2Cough  responding to symptoms lec. 2
Cough responding to symptoms lec. 2Siham Gafer
 
3 Asthma and COPD Management
3 Asthma and COPD Management3 Asthma and COPD Management
3 Asthma and COPD ManagementYaser Ammar
 
Asthma-COPD Overlap Translating Guidelines into Clinical Pracice - Cases
  Asthma-COPD Overlap Translating Guidelines into Clinical Pracice - Cases  Asthma-COPD Overlap Translating Guidelines into Clinical Pracice - Cases
Asthma-COPD Overlap Translating Guidelines into Clinical Pracice - CasesAshraf ElAdawy
 
Case presentation on alcoholic liver disease
Case presentation on alcoholic liver diseaseCase presentation on alcoholic liver disease
Case presentation on alcoholic liver diseaseRavali Naidu
 
Pharmacology of drugs used in hyper reactive airway diseases
Pharmacology of drugs used in hyper reactive airway diseasesPharmacology of drugs used in hyper reactive airway diseases
Pharmacology of drugs used in hyper reactive airway diseasesShekhar Verma
 
Emergencies Handbook.pub A4.FINAL VERSION July 2015.pdf
Emergencies Handbook.pub A4.FINAL VERSION July 2015.pdfEmergencies Handbook.pub A4.FINAL VERSION July 2015.pdf
Emergencies Handbook.pub A4.FINAL VERSION July 2015.pdfAaronNameerAbrarRahm
 
Case presentation on abdominal migraine
Case presentation on abdominal migraineCase presentation on abdominal migraine
Case presentation on abdominal migraineLogeshwary M
 

Similar to Covid 19 Respiratory (20)

Cough, diagnosis and its treatment
Cough, diagnosis  and its treatmentCough, diagnosis  and its treatment
Cough, diagnosis and its treatment
 
Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024
 
Paediatrics house officer guide hospital kulim
Paediatrics house officer guide hospital kulimPaediatrics house officer guide hospital kulim
Paediatrics house officer guide hospital kulim
 
L2 bronchial asthma
L2 bronchial asthmaL2 bronchial asthma
L2 bronchial asthma
 
asthma .pptx
asthma  .pptxasthma  .pptx
asthma .pptx
 
Cold and flu, its diagnosis and treatment for Pharmacist
Cold and flu, its diagnosis and treatment for PharmacistCold and flu, its diagnosis and treatment for Pharmacist
Cold and flu, its diagnosis and treatment for Pharmacist
 
Approach patient with cough
Approach patient with cough Approach patient with cough
Approach patient with cough
 
Cough responding to symptoms lec. 2
Cough  responding to symptoms lec. 2Cough  responding to symptoms lec. 2
Cough responding to symptoms lec. 2
 
3 Asthma and COPD Management
3 Asthma and COPD Management3 Asthma and COPD Management
3 Asthma and COPD Management
 
Copd case study-numberthree
Copd case study-numberthreeCopd case study-numberthree
Copd case study-numberthree
 
Copd case study-numberthree
Copd case study-numberthreeCopd case study-numberthree
Copd case study-numberthree
 
Copd case study-numberthree
Copd case study-numberthreeCopd case study-numberthree
Copd case study-numberthree
 
Copd case study-numberthree
Copd case study-numberthreeCopd case study-numberthree
Copd case study-numberthree
 
Respiratory.pdf
Respiratory.pdfRespiratory.pdf
Respiratory.pdf
 
Asthma-COPD Overlap Translating Guidelines into Clinical Pracice - Cases
  Asthma-COPD Overlap Translating Guidelines into Clinical Pracice - Cases  Asthma-COPD Overlap Translating Guidelines into Clinical Pracice - Cases
Asthma-COPD Overlap Translating Guidelines into Clinical Pracice - Cases
 
Case presentation on alcoholic liver disease
Case presentation on alcoholic liver diseaseCase presentation on alcoholic liver disease
Case presentation on alcoholic liver disease
 
Pharmacology of drugs used in hyper reactive airway diseases
Pharmacology of drugs used in hyper reactive airway diseasesPharmacology of drugs used in hyper reactive airway diseases
Pharmacology of drugs used in hyper reactive airway diseases
 
Emergencies Handbook.pub A4.FINAL VERSION July 2015.pdf
Emergencies Handbook.pub A4.FINAL VERSION July 2015.pdfEmergencies Handbook.pub A4.FINAL VERSION July 2015.pdf
Emergencies Handbook.pub A4.FINAL VERSION July 2015.pdf
 
Case presentation on abdominal migraine
Case presentation on abdominal migraineCase presentation on abdominal migraine
Case presentation on abdominal migraine
 
bronchial asthma.ppt
bronchial asthma.pptbronchial asthma.ppt
bronchial asthma.ppt
 

Recently uploaded

Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfAyushMahapatra5
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhikauryashika82
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...KokoStevan
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.MateoGardella
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfChris Hunter
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxnegromaestrong
 

Recently uploaded (20)

Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 

Covid 19 Respiratory

  • 1. COVID 19: RESPIRATORY CONDITIONS www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér
  • 2. Asthma • Asthmatics with mild–moderate disease usually have normal lungs when well controlled. • Maintenance therapy will not require changing when they are well as as inhaled corticosteroids from used in asthma therapy have not been shown to be immunosuppressant and should be continued. • BTS guidelines on provision of a rescue pack for patients with a good understanding of their personalised asthma action plan may be sensible in the current health climate. Issue a peak flow meter so they can monitor at home. Rescue packs should be issued as acute and SHOULD NOT be on repeat as each exacerbation requires a review. • Acute exacerbations of asthma should be treated in the normal way, including oral steroids. www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér
  • 3. Acute asthma vs. COVID-19 • Differentiating an acute exacerbation of asthma from COVID-19 may be difficult. Pragmatically, fever and change of taste/smell are unusual in asthma. Decide (as best you can) which is more likely. If COVID-19 suspected, remember: • Oral steroids are NOT a treatment for COVID-19. In practice, this means that if an asthmatic has mild COVID symptoms but with no significant asthma symptoms, we should not give prophylactic oral steroids. • However, if typical asthma exacerbation features are dominant (wheeze/bronchospasm), oral steroids should be used as per asthma guidelines. Use shortest duration. • Twice as much steroids when ill under the guidance of medical practitioner. www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér
  • 4. ASTHMA www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér Concern Management Wheeze/Bronchospasm But NO fever Treat as an exacerbation. Possible COVID-19 ie SOB/Cough/fever  Fever: Paracetamol & oral fluids  Possible Secondary Bacterial Pneumonia: As per severity of symptoms choose: Moderate: Amoxicillin 500mg TDS+ Clarithromycin 500mg BD for 7 days OR Doxycycline 200mg stat and then 100mg OD for 6 days Moderately severe: Co-Amoxiclav 625mg TDS + Clarithromycin 500mg BD for 7 days OR Azithromycin 500mg OD for 5/7 Days (If no other option).  Wheezing/SOB: High dose of SABA (4-8 puffs via large volume spacer). Do not introduce nebules, only to be used if patient previously using nebules.
  • 5. COPD • There is NO evidence for ‘just in case antibiotics’ OR using prophylactic antibiotics. • Treat apparent exacerbations as you normally would, irrespective of possible organism, which means: • Use antibiotics if suspected bacterial infective exacerbations (more sputum/change in sputum colour). • Consider oral steroids for increased breathlessness: but first check that symptoms can’t be managed with increasing bronchodilators, breathing exercises, pacing. Have a lower threshold to use steroids in those with asthma–COPD overlap or previous raised eosinophils as they are likely to get greater benefits. Do not use if patient has a fever. If using, offer 30mg prednisolone for 5 days. • Remember, anxiety can also drive breathlessness/tachycardia: a phone/video consultation can help reassure people. www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér
  • 6. If oxygen sats are available, a significant change from baseline is: www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér Mild: <2% below baseline Moderate: 3– 4% below baseline sats Severe: ≥5% below baseline sats
  • 7. www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér COPD Worsening SOB But No Fever  Use high dose SABA (4-8 puffs via large volume spacer). Do not introduce nebules, however, if patient has already got nebules may step up the dose.  Oral steroids only to be considered if 1. Mixed COPD+ Asthma 2. COPD with h/o high Eosinophil ≥0.3 COPD Increase sputum amount/ Sputum discolouration BUT No chest pain No fever No loss of Activity of Daily Living (ADL) Treat as infective COPD Exacerbation Reminder (No oral steroids to be used)
  • 8. COPD : POSSIBLE COVID 19 Possible COVID-19 with SOB/New continuous cough/ fever/ Chest tightness or pain/ Decline in ADL/Lethargy www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér  Fever: Paracetamol and oral fluids.  Secondary bacterial Pneumonia As per severity of symptoms choose: Moderate: Amoxicillin 500mg TDS+ Clarithromycin 500mg BD for 7 days OR Doxycycline 200mg stat and then 100mg OD for 6 days AND: Treat SOB using SABA high dose via large volume spacer. Patient may use nebules if has got them at home. Moderately severe: Co-Amoxiclav 625mg TDS + Clarithromycin 500mg BD for 7 days OR Azithromycin 500mg OD for 5/7 Days (If no other option). Please note this group may be appropriate for COVID-HOT hub assessment and management AND  Treat SOB using SABA high dose via large volume spacer. Patient may use nebules if has got them at home.
  • 9. Interstitial Lung Disease www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér  Currently under Shielding (12 weeks)  Will not do well with intubation/ mechanical ventilation  Likely to become hypoxic very quickly  Mostly have advanced care plan in place If has developed symptoms of possible COVID-19 →  Admission will be guided by deterioration of SpO2 from baseline (up to 2% decline is mild, 2-4% is moderate and ≥5% decline from baseline is severe deterioration)  Consult Advanced care plan for management decisions  Antifibrotic Biologics can be paused for up to 8 weeks  Do not stop Long term Oral Steroids  DMARDs to be paused and re-initiated 2 weeks after recovery.  Elongate the shielding time (Beyond 12 weeks)
  • 10. Obstructive Sleep Apnea www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér Have normal Lung function Should they develop COVID-19 symptoms (A new continuous cough/fever/chest tightness/SOB/lethargy/decline in ADL) follow the decision tree as for all members of public Should these patient need hospitalisation, advise to take CPAP machine with them to use at hospital
  • 11. Bronchietasis Development of discoloured purulent sputum But No chest pain No fever No loss of Activity of Daily Living (ADL) Treat as an exacerbation with standard dose Amoxicillin or Doxycycline for 10-14 days Do not collect sputum samples If non-respondent to the above may consider Ciprofloxacin but seek specialist advice.
  • 12. Bronchietasis: Possible COVID 19 www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér Possible COVID-19 i.e. • SOB/New continuous cough/ fever • Chest tightness or pain • Decline in ADL • Lethargy With/without purulent sputum Fever: Paracetamol and oral fluids + As per severity of symptoms choose: Moderate: Amoxicillin 500mg TDS+ Clarithromycin 500mg BD for 7 days OR Doxycycline 200mg stat and then 100mg OD for 6 days AND: Treat SOB using SABA high dose via large volume spacer. Patient may use nebules if has got them at home. Moderately severe: Co-Amoxiclav 625mg TDS + Clarithromycin 500mg BD for 7 days OR Azithromycin 500mg OD for 5/7 Days (If no other option). Please note this group may be appropriate for COVID-HOT hub assessment and management
  • 13. References • References: • http://primarycarepathways.co.uk/covid-19/clinical- assessment/pathways/177-barnet-primary-care-pathway-during-covid19- v2-0-pdf/file • Accessed 03/04/2020 • http://primarycarepathways.co.uk/covid-19/clinical-assessment/241- primary-care-and-community-respiratory-resource-pack-during-covid-19- nhs-london-clinical-networks/file • Accessed 03/04/2020 • The above guidance is correct and up to date as of 03/04/2020. It is subject to amendment as the pandemic progresses. www.belmatt.co.uk. Prepared by Aneela Tehseen and Jeshni Amblum-Almér